Hong Jen Chang
Chief Executive Officer bij EUSOL BIOTECH CO.,LTD.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Ming-Chu Hsu | M | - |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | 23 jaar |
Sonny Hsiao | M | - |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | 7 jaar |
Yu Te Chang | M | - |
Medeon Biosurgical, Inc.
Medeon International, Inc.
| 12 jaar |
Jun Liu | M | 56 | 8 jaar | |
Shou-Chuan Ho | M | - |
Taiwan Genome Sciences, Inc.
Taiwan Global BioFund
Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements.
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | 11 jaar |
Hsiu Mei Huang | F | - |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | - |
Yi Ju Chen | M | - | 12 jaar | |
Xiao Ying Gao | M | 74 |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | - |
Weng Foung Huang | M | - | 13 jaar | |
Patrick Yang | M | 75 |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | 7 jaar |
Ching Yi Chen | M | - | - | |
Po Yung Chu | M | - |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | 9 jaar |
Philip Huang | M | - | 6 jaar | |
Hui Ching Huang | F | - | 10 jaar | |
Ming Tse Chen | M | - | - | |
Ju Yi Lin | F | 58 | 4 jaar | |
Chia Lin Chen | M | - | 9 jaar | |
Richard Lue | M | - | 8 jaar | |
Yan Ta Lai | M | - | 7 jaar | |
Wan Ya Chang | M | - | - | |
Li Chen Hsiao | M | - |
YFY Biotech Management Co
YFY Biotech Management Co Investment ManagersFinance YFY Biotech Management Co. Ltd. (YFYBM) is a private equity investment firm located in Taipei, Taiwan. Established in 2003, they are subsidiary of the Yuen Foong Yu Group Co. Ltd., founded in 1926 with their core business initially focused on paper manufacturing. YFYBM is the investment manager of biotechnology private equity fund | - |
Kuang I Ou Yang | M | - | 5 jaar | |
Hui Chen Liu | M | - | 12 jaar | |
Tse Min Chen | M | - | 36 jaar | |
Jung Kai Shao | M | - |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | 13 jaar |
Hung Mo Li | M | - | 6 jaar | |
Perry Schiro | M | - |
MiCareo, Inc.
MiCareo, Inc. BiotechnologyHealth Technology MiCareo, Inc. provides tools for the analysis of rare cells. It circulates tumor cell platform does rare cell isolation and analysis for cancer prognosis, treatment development, and efficacy evaluation. The firm’s product MiSelect starts with whole blood labeled with any fluorescent cell surface antibody or cocktail of multiple antibodies. The company was founded by Perry Schiro and Daniel T. Chiu in 2011 and is headquartered in Taipei, Taiwan. | 13 jaar |
Chun Hsiung Chang | M | - | 9 jaar | |
Yeh Hung Chang | M | - | 5 jaar | |
Jong-Jin Lim | M | - |
NeuroSky, Inc.
NeuroSky, Inc. SemiconductorsElectronic Technology NeuroSky, Inc. develops biosensor technology services. Its biosensors, biometric algorithms, reference designs, and big data analytics enable leading-edge innovation in mhealth products and services for measuring body and mind performance. The company was founded by Hyung Koo Lee and Jong Jin Lim in 2004 and is headquartered in San Jose, CA. | 20 jaar |
Jen Fang Li | M | - | 3 jaar | |
Chi Hang Yang | M | - | 9 jaar | |
Shao Wen Sun | M | - | 9 jaar | |
Ted Chaung | M | - |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | - |
Shu Li Tsai | M | - | 9 jaar | |
Kuo Chih Yu | M | - |
Taiwan Global BioFund
Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements.
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | - |
Ting Wong Cheng | M | 82 | 1 jaar | |
Wei Jao Chen | M | - |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | - |
De Qian Wang | M | 73 | 2 jaar | |
Jung Chin Lin | M | 70 |
Medeon International, Inc.
| - |
Chun-Ying Yeh-Huang | F | 65 | 14 jaar | |
Wei Chun Kao | M | - | 1 jaar | |
Te Fang Chu | M | - | 1 jaar | |
Lan Bo Chen | M | 80 |
YFY Biotech Management Co
YFY Biotech Management Co Investment ManagersFinance YFY Biotech Management Co. Ltd. (YFYBM) is a private equity investment firm located in Taipei, Taiwan. Established in 2003, they are subsidiary of the Yuen Foong Yu Group Co. Ltd., founded in 1926 with their core business initially focused on paper manufacturing. YFYBM is the investment manager of biotechnology private equity fund | - |
Li Chu Lo | M | - | 3 jaar | |
Chih Lung Shen | M | 59 | 9 jaar | |
Cheng Yue Cheng | M | - | 14 jaar | |
Kuo-Hsi Wang | M | - |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | 15 jaar |
Sheng Fu Yu | M | 79 | 5 jaar | |
David Chung | M | - |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | 21 jaar |
Ben Xiao | M | 42 | 2 jaar | |
Chia-Ying Ma | M | - | 9 jaar | |
Joe Hsueh | M | - |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | 23 jaar |
Chun Yue Lin | F | - | - | |
Shan Fu | M | 56 | 8 jaar | |
Yue Hui Su | M | - | 3 jaar | |
Lan Hu | F | 53 | 5 jaar | |
Tsung Jen Yang | M | - | 6 jaar | |
Yi Fan Chen | M | 44 | 4 jaar | |
Shu-o Wu Yang | M | - |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | - |
Li Ko Hsu | M | - | 6 jaar | |
Wing Yat Lui | M | 35 | 5 jaar | |
MIng Tsung Kao | M | - | 5 jaar | |
Hsiu Yuan Li | F | - |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | - |
Hsin Yuan Fang | M | - | 6 jaar | |
Wei Dong Liu | M | 56 | 1 jaar | |
Xiaobao Chen | M | 42 | 8 jaar | |
Ming Liu | F | 63 | 7 jaar | |
Lapyuen Lam | M | 66 | 2 jaar | |
Ya Jun Wang | M | - | 2 jaar | |
Donglian Liu | M | 55 | 8 jaar | |
Rongjin Lin | M | - | - | |
David Smith | M | 64 |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | 2 jaar |
Chien Wen Han | M | - |
Taiwan Global BioFund
Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements. | - |
Hai Yi Ma | M | - | 7 jaar | |
Shih Chang Hsu | M | 61 | - | |
Samuel Chen | M | 73 | 3 jaar | |
Chin Tsai Fan | M | - |
Taiwan Pharmaceutical Manufactureres Association
| - |
Ling Chin Lee | F | 75 |
Taiwan Pharmaceutical Manufactureres Association
| 33 jaar |
Ssu Cheng Liu | M | - |
Taiwan Genome Sciences, Inc.
| - |
Daniel T. Chiu | M | 52 |
MiCareo, Inc.
MiCareo, Inc. BiotechnologyHealth Technology MiCareo, Inc. provides tools for the analysis of rare cells. It circulates tumor cell platform does rare cell isolation and analysis for cancer prognosis, treatment development, and efficacy evaluation. The firm’s product MiSelect starts with whole blood labeled with any fluorescent cell surface antibody or cocktail of multiple antibodies. The company was founded by Perry Schiro and Daniel T. Chiu in 2011 and is headquartered in Taipei, Taiwan. | 13 jaar |
Jake Chuang | M | - |
NeuroSky, Inc.
NeuroSky, Inc. SemiconductorsElectronic Technology NeuroSky, Inc. develops biosensor technology services. Its biosensors, biometric algorithms, reference designs, and big data analytics enable leading-edge innovation in mhealth products and services for measuring body and mind performance. The company was founded by Hyung Koo Lee and Jong Jin Lim in 2004 and is headquartered in San Jose, CA. | - |
Hsiu Hui Li | F | - | 12 jaar | |
Chung Fu Wu | M | - |
Taiwan Global BioFund
Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements. | - |
Man Hsiang Li | M | - | 12 jaar | |
Hsiang Min Huang | M | - | 8 jaar | |
Hsi Chieh Wang | M | - | 12 jaar | |
Wen Hung Huang | M | - |
Taiwan Global BioFund
Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements. | - |
James Sullivan | M | - |
NeuroSky, Inc.
NeuroSky, Inc. SemiconductorsElectronic Technology NeuroSky, Inc. develops biosensor technology services. Its biosensors, biometric algorithms, reference designs, and big data analytics enable leading-edge innovation in mhealth products and services for measuring body and mind performance. The company was founded by Hyung Koo Lee and Jong Jin Lim in 2004 and is headquartered in San Jose, CA. | - |
Hironobu Tamba | M | - |
NeuroSky, Inc.
NeuroSky, Inc. SemiconductorsElectronic Technology NeuroSky, Inc. develops biosensor technology services. Its biosensors, biometric algorithms, reference designs, and big data analytics enable leading-edge innovation in mhealth products and services for measuring body and mind performance. The company was founded by Hyung Koo Lee and Jong Jin Lim in 2004 and is headquartered in San Jose, CA. | 11 jaar |
Tung Lung Hsu | M | - | 16 jaar | |
Pi Chu Tsai | M | - | 10 jaar | |
Jui-Lin Chen | M | - |
MiCareo, Inc.
MiCareo, Inc. BiotechnologyHealth Technology MiCareo, Inc. provides tools for the analysis of rare cells. It circulates tumor cell platform does rare cell isolation and analysis for cancer prognosis, treatment development, and efficacy evaluation. The firm’s product MiSelect starts with whole blood labeled with any fluorescent cell surface antibody or cocktail of multiple antibodies. The company was founded by Perry Schiro and Daniel T. Chiu in 2011 and is headquartered in Taipei, Taiwan. | - |
Wen Hung Huang | M | - | 7 jaar | |
Chih Hsiung Wu | M | - | 8 jaar | |
Jessica Lee | F | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Chin Ting Huang | M | - | - | |
Lijun Sun | M | 61 | 3 jaar | |
Hui Mei Kang | F | 53 | - | |
Che Jen Chuang | M | - | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Taiwan | 68 | 68.00% |
Kaaimaneilanden | 24 | 24.00% |
Hongkong | 13 | 13.00% |
Verenigde Staten | 5 | 5.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Hong Jen Chang
- Persoonlijk netwerk